PRESS

The talk on the town.

Our AI-driven voice analysis is making a real impact on mental healthcare.
Read what the press has to say about Kintsugi.
August 27, 2021
Mercom Capital

Kintsugi Raises $8 Million for Vocal Biomarker App

Kintsugi Raises $8 Million, led by Acrew Capital, to scale its enterprise API platform KiVA™
Read Full Article
August 27, 2021
Fierce Healthcare

AI Startup Kintsugi Secures $8M from Investors to Build Out Voice Biomarker-Based Mental Health Tech

Kintsugi raises $8M seed from venture and National Science Foundation to expand commercialization of novel voice biomarker technology that detects signs of clinical depression and anxiety from short clips of free-form speech.
Read Full Article
August 26, 2021
Mobi Health News

Vocal Biomarker Company Kintsugi Scores $8M

Kintsugi raises $8M seed to expand enterprise commercialization of rapid, voice-based mental health screening
Read Full Article
May 24, 2021
Forbes

Forbes: AI Can Now Detect Depression From Your Voice, And It’s Twice As Accurate As Human Practitioners

Check out Kintsugi featured in Forbes about the future of AI in detecting depression and anxiety.
Read Full Article
May 15, 2021
NSF

NSF Award Announcement: SBIR Phase II:  Augmenting virtual healthcare with Voice Biomarkers

Kintsugi was awarded an NSF SBIR Phase II grant to develop smart, robust healthcare infrastructure in the U.S. by leveraging machine learning and AI.
Read Full Article